论文部分内容阅读
目的:析“蚓激酶胶囊+普罗布考片”治疗脑梗死颈动脉不稳定粥样斑块的疗效。方法:择2012年10月至2014年10月接收的脑梗死患者,共140例。随机分成实验组与对照组。实验组行“蚓激酶胶囊+普罗布考片”治疗,对照组单用普罗布考片。观察两组颈动脉不稳定粥样斑块的变化情况,并比较疗效。结果:实验组颈动脉不稳定粥样斑块的改善情况明显优于对照组(P<0.05)。实验组疗效的总有效率为95.71%,对照组为82.86%。实验组明显高于对照组(P<0.05)。结论:选取“蚓激酶胶囊+普罗布考片”疗法,对脑梗死患者实施治疗,可加快其颈动脉不稳定粥样斑块的改善速度,疗效甚好。
Objective: To analyze the efficacy of “Lumbukin capsule + probucol tablets” for the treatment of unstable atherosclerotic plaque in patients with cerebral infarction. Methods: Choose from October 2012 to October 2014 received a total of 140 patients with cerebral infarction. Randomly divided into experimental group and control group. Experimental group “lumbrokinase capsules + probucol tablets ” treatment, the control group with probucol tablets alone. The changes of carotid instability plaque in two groups were observed, and the curative effect was compared. Results: The improvement of carotid atherosclerotic plaque in the experimental group was significantly better than that in the control group (P <0.05). The total effective rate of the experimental group was 95.71%, the control group was 82.86%. The experimental group was significantly higher than the control group (P <0.05). Conclusion: “Rubupronase capsules plus probucol tablets” therapy can improve the speed of improvement of unstable carotid atherosclerotic plaques in patients with cerebral infarction, and the effect is very good.